Quantcast

Latest genomics Stories

2014-05-23 08:24:42

ROCKVILLE, Md., May 23, 2014 /PRNewswire/ -- Strand Genomics Inc., a new generation healthcare innovation company headquartered in Bangalore, India, today announced that Ravi Venkatesan, the Chairman of Microsoft India from 2004-2011 who helped to build and expand Microsoft's position in India as the company's largest presence outside of the U.S., has joined the Strand Board of Directors. Mr. Venkatesan is the author of the acclaimed Conquering the Chaos: Win in India, Win Everywhere,...

2014-05-22 23:16:14

Zymo Research Corporation, The Epigenetics Company, continues to expand its portfolio of products and services for researchers and clinicians alike. Today, the company has announced their new offering of Next-Gen sequencing-based Microbiomics Services that include Taxonomic Profiling and Microbiome Shotgun Sequencing. Irvine, California (PRWEB) May 22, 2014 Microbial communities thrive in diverse niches under different conditions where they can elicit a strong influence on their...

2014-05-22 13:17:37

Indiana University School of Medicine A group of 11 genes can successfully predict whether an individual is at increased risk of alcoholism, a research team from the United States and Germany reported Tuesday. "This powerful panel of just 11 genes successfully identified who has problems with alcohol abuse and who does not in tests in three patient populations on two continents, in two ethnicities and in both genders," said Alexander B. Niculescu III, M.D., Ph.D., principal...

2014-05-22 12:27:49

LONDON, May 22, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Life Science Tools and Reagents: Global Marketshttp://www.reportbuyer.com/pharma_healthcare/medical_devices/life_science_tools_reagents.htmlSTUDY OBJECTIVESNewly developed life sciences tools and reagents promote interdisciplinary research environments that integrate basic biological science with engineering and computational disciplines. BCC Research's goal in conducting this study is to...

2014-05-20 23:11:18

GB HealthWatch, a nutritional genomics company, announces the release of a new iPhone app, HealthWatch 360, an innovative health app designed to help people lose weight, boost energy, reduce stress, control blood pressure and prevent diet-related chronic diseases like type 2 diabetes and heart disease. Nutritional science is seamlessly integrated into the app’s simple layout; HealthWatch 360 is much more than a calorie counter, it is like a personal nutritionist in your pocket. San...

2014-05-20 16:26:37

HILDEN, Germany and GERMANTOWN, Maryland, May 20, 2014 /PRNewswire/ -- - New biomedical content resources strengthen QIAGEN's industry-leading bioinformatics portfolio - Expansion will offer clinical researchers the most comprehensive, high-quality and up-to-date literature source for gene variant and disease phenotype associations - Expert-curated hereditary variants from HGMD are now available to customers using...

2014-05-20 08:32:32

SAN DIEGO, May 20, 2014 /PRNewswire/ -- BioNano Genomics, the leading genome mapping instrument company, announced today the appointment of Mr. Mike Ward as a member of the senior executive management team and vice president, corporate development. Mr. Ward has more than 20 years of life sciences-dedicated investment banking, venture capital and private equity experience. http://photos.prnewswire.com/prnvar/20140519/89015 "With his impressive track record in mergers and...

2014-05-19 12:27:37

LONDON, May 19, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Cancer Profiling and Pathways: Technologies and Global Marketshttp://www.reportbuyer.com/pharma_healthcare/diseases/cancer/cancer_profiling_pathways.htmlSTUDY GOALS AND OBJECTIVESThis BCC Research report, BIO073B: Cancer Profiling and Pathways: Technologies and Global Markets, provides a detailed overview and thorough analysis and insight of the present and future cancer profiling and...

2014-05-17 12:20:23

ANN ARBOR, Mich. and PHOENIX, May 17, 2014 /PRNewswire-USNewswire/ -- Paradigm today announced that Dr. Robert Penny, CEO, will speak at the Moffitt Cancer Center Personalized Medicine Program: Beyond the Promise: Addressing Evidence and Value in Personalized Medicine on Saturday, May 17(th), 2014 at 1:00 p.m. EDT in Tampa, FL. http://photos.prnewswire.com/prnvar/20140517/88676 Paradigm's next-generation sequencing-based test PCDx, analyzes the DNA and RNA (the cancer cell's...

2014-05-15 23:04:23

Dr. Mostafa Ronaghi brings decades of experience in developing world class genomic and personalized medicine tools to BaseHealth’s board Redwood City, CA (PRWEB) May 15, 2014 BaseHealth, the maker of the integrated health management platform GenophenTM, today announced the addition of Dr. Mostafa Ronaghi to the company’s Board of Directors. Dr. Ronaghi is the current Chief Technology Officer of Illumina, Inc., the leader in next-generation sequencing technologies. He is also a serial...


Word of the Day
jument
  • A beast of burden; also, a beast in general.
'Jument' ultimately comes from the Latin 'jugum,' yoke.
Related